Introduction
It is estimated that 50% of patients with metastatic malignancies have pleural effusion. Most of the pleural effusions occur due to metastatic spread of the tumor to the pleural surface. This is generally associated with cough and dyspnea, which can significantly affect the quality of life [1] .
Methods of treatment of refractory malignant pleural effusion (MPE) includes local therapeutic methods such as thoracentesis, pleurodesis, pleurectomy, or pleuroperitoneal shunting. Pleurodesis, through instilling sclerosing material into the pleural space, is one of the most important methods for the management of MPE [2] .
The criteria for successful pleurodesis in a patient with MPE include complete fluid drainage (100 ml drainage in 24 h), re-expansion of the lung, and relatively long survival rate. Pleural fluid (pH: 7.20) is a good predictor for the presence of a trapped lung, failure of pleurodesis, and short life expectancy [3] .
MPE has certain criteria under chest ultrasound (US) which include diaphragmatic and parietal pleura nodule or nodules, pleural thickening, and metastasis [3] .
Pleurodesis is the best palliative measure in cases of recurrent massive MPEs and severe dyspnea. Successful pleurodesis can be determined by sonography. Absence of sliding of the pleura is a sign of successful pleurodesis [4] .
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If there is failure of pleurodesis, sonography can detect residual effusion with septation, lung infiltration, or partial atelectasis of the lung better than radiological imaging methods [5] . 
Patients and methods

Inclusion criteria
Patients who proved to have MPE, the diagnosis was reached through the following.
(1) The clinical findings included [6] : (a) History of anorexia, loss of weight, dyspnea, and chest pain. (b) Local chest signs revealed mainly findings related to pleural involvement including decrease breath sounds and stony dullness on percussion overlying the effusion. (c) History of recurrent or rapidly accumulating pleural effusion. (d) History of malignancy outside lung, for example ovarian, hepatic, breast, and colon. (2) The radiographic findings included [7] :
(a) Classical radiological presentation of free pleural effusion (whether by plain chest radiography or computed tomography). (b) Other radiographic features, for example pulmonary nodules or masses, pleural thickening, pleural nodules, or masses. (3) Pleural fluid examination (gross appearance, biochemical tests, total and differential leukocyte, cytological examination). (4) Pleural tissue evaluation for malignancy through Abram's biopsy, thoracoscopic biopsy, or Tru-cut needle biopsy.
Exclusion criteria [6] (1) Patients with encysted pleural effusion.
(2) Incomplete lung re-expansion after chest tube insertion.
After diagnosis of malignant pleural effusion thoracostomy tube was inserted [2] . After instillation of local anesthesia with 1% lidocaine solution, a no. 28
intercostal tube was inserted through the fifth intercostal space at the level of midaxillary line into the pleural cavity. Then, the intercostal tube was connected to underwater seal system. When the chest radiological imaging showed complete lung reexpansion, pleurodesis was performed at the patient's bedside ( Fig. 1 ).
Patient groups
The patients were divided into four groups according to the type of the sclerosing agent:
(1) Group 1-tetracycline is used to induce pleurodesis in eight patients: the fluid for pleurodesis consisted of 12.5 ml of 2% lidocaine made up to 50 ml with normal saline. Tetracycline powder obtained from tetracycline capsules (35 mg/kg body weight) was mixed to the fluid. The mixture was drawn into a syringe and then instilled into the pleural cavity through the intercostal tube. Then the tube was clamped for 2 h. After declamping the thoracostomy tube, the tube was left for drainage for up to 72 h, without negative suction application, and when the drained fluid was less than 250 ml/24 h, the tube was removed [5] . (2) Group 2-fluorouracil is used to induce pleurodesis in eight patients: 5 fluorouracil was administered intrapleurally in doses of 2 g diluted in 50 ml of saline 0.9% plus 10 ml of 2% xylocaine. After intrapleural injection of the pleurodetic agent, the tube was clamped and the patient was rotated for 1 h, to guarantee adequate pleural distribution. After 1 h, the tube was opened for up to 72 h drainage, without negative suction application, and when the fluid drained was less than 250 ml/24 h, the tube was removed [8] .
Figure 1
Pleural thickening due to fusion of visceral and parietal pleura after pleurodesis.
(3) Group 3-povidone-iodine 10% is used to induce pleurodesis in eight patients: a mixture of 2 mg/kg lidocaine 2% and 20 ml of 10% of povidone-iodine and 80 ml of normal saline was injected into the pleural cavity through the tube. Then the intercostal tube was clamped for 2 h. To circulate the mixture, the position of these patients was changed within 2 h and then released. The tube was opened for drainage for up to 24 h to drain the injected amount of fluid then the tube was removed as soon as the drainage decreased [2] . (4) Group 4-spontaneous pleurodesis: indwelling pleural catheter (IPC) was inserted with sonographic guidance and topical anesthesia (mepivacaine 2%). After placement of the catheter, the patients and caregivers were educated to drain their effusion. They were reviewed within 5-10 days after insertion of the catheter and additional visits were arranged if clinically indicated. When the drainage became less than 50 ml on 3 consecutive days the IPC can be removed [9, 10] .
Chest ultrasound is done to confirm successful pleurodesis.
Transthoracic US examination technique: the system used was SonoScape SSI 4000 (digital color Doppler ultrasound system, model SSI 4000, Guangdong, China) in the Chest Department, Ultrasound Unit. All patients were examined in supine and sitting positions with arms elevated to above their heads to widen the intercostal spaces for good visualization of pleural lines. Curvilinear probe (3.5 MHz) and linear probe (5 MHZ) by B-mode were used. US was used to detect the sliding sign before injection of any sclerosing agent [11] .
Examination technique
The correct scan was intercostal with the maximum extension of the visible pleural line. The anterior chest wall was delineated from the sternum to the anterior axillary line and was subdivided into upper and lower halves (approximately from the clavicle to the secondthird intercostal spaces and from the third space to the diaphragm). The lateral zone was delineated from the anterior to the posterior axillary line and was subdivided into upper and basal halves [12] .
Usually, the dorsal and lateral images are obtained in the sitting position, whereas the supine position is used for visualizing the ventral side. The chest wall was divided into eight areas, and one scan for each area was obtained. The examiner is able to visualize the region behind the shoulder blade, if the patient puts his/her hand on the other shoulder. Turning the probe in different positions provides the examiner with a three-dimensional image. During every step of examination, the user should determine the breathrelated moving of the pleura, the so-called sliding sign [13] .
So the affected hemithorax was divided into eight areas. Anteriorly: supramammary, mammary, and inframammary; laterally: upper and lower axillary areas; back: suprascapular, interscapular, and infrascapular.
Score was given to each area according to the presence of lung sliding sign:
(1) Sliding sign present 1.
(2) No sliding 0.
There are two possibilities: the sliding sign present (the score of the patient equal or >5) denoting good drainage of the effusion and the patient will need pleurodesis.
The sliding sign was lost denoting adherence of two pleura together the chest tube removed for follow-up by chest US after 1 month. If the score of the patient is below the cutoff point 5 it means successful pleurodesis.
Statistical analyses
All statistical analyses were carried out using the SPSS (statistical package for the social sciences software) statistical package version 20.0 (SPSS Inc., Chicago, Illinois, USA) for Windows. Quantitative data were expressed as mean and SD and analyzed by applying Student's t-test for comparison of two groups of normally distributed variables. The results of the 't'value is then checked on Student's 't'-table to find out the significance level (P value) according to the degree of freedom. All these tests were used as tests of significance at P value less than 0.05.
Results
Of the 32 patients who had been referred for pleurodesis due to MPE, four patients were men and 28 were women with a mean age of 51.59±9.13, 56.2% were smokers; 12.5% came with primary MPE (mesothelioma), and 87.5% with metastatic pleural effusion [lung cancer, breast cancer, colon cancer, hepatocellular carcinoma (HCC), prostatic cancer, uterine cancer, ovarian cancer, bladder cancer]. They were diagnosed by different methods as illustrated in Table 1 .
Chest US was done to detect the presence or absence of pleural thickening or pleural nodules/masses as illustrated in Tables 2 and 3 .
Lung sliding score was calculated by US before pleurodesis (Table 4 ).
Patients were divided into four equal groups according to the method of pleurodesis (tetracycline 25%, povidone-iodine 25%, flurouracil 25%, and spontaneous 25%).
After pleurodesis lung sliding score was calculated using US to detect successful or failed pleurodesis as illustrated in Tables 5 and 6 .
Discussion
The study was conducted in Chest Department, Zagazig University Hospital from October 2016 to August 2017. The study included 32 patients proved to have MPE with a mean age of 53 years (range: 21-65) which is comparable to Wong et al. [14] , where the age of the patients was 59.3±14.3, Sartori et al. [15] , where the age of patients was 60 years (range: 40-82).
The main complaints were dyspnea in 100% of the patients and chest pain in 93.8% of the patients. It is comparable to the study of Tettey et al. [5] , which included 83 women with a mean age of 51.1 years. Dyspnea was found in 38 (100%) of the studied patients. Chest pain was found in 36 (94%), cough in 32 (84%), malaise in nine (23%), and weight loss in 10 (26%).
In this study, 12.5% of the patients came with primary MPE (mesothelioma) and 87.5% came with metastatic MPE. In this study, pleural thickening was found in 21 (65.6%); the thickness was 4.65±3.63. Pleural nodule or masses were costal in 15.6%, diaphragmatic in 6.3% both in 12.5% of the patients. In El Hadidy et al. [16] , 28 patients out of 30 (93.4%) presented with multiple small nodules over the pleural surface, one patient presented with a mass with small nodules, and in another patient the pleura was free of nodules.
The patients were diagnosed to have MPE by different methods. Abrams needle biopsy in 3.1% of the patients, thoracoscopic biopsy in 9.4% of the patients, Tru-cut biopsy in 9.4% of the patients, cytology+biopsy in 68.8% of the patients, and cytology+fiberoptic bronchoscopy in 9.4% of the patients.
Chest US was done before pleurodesis to detect the lung sliding score. The patients then divided into four equal groups according to the method of pleurodesis (tetracycline, fluorouracil, povidoneiodine, and spontaneous).
Then US was done after pleurodesis to detect successful or failed pleurodesis using the lung sliding score. If the score is less than 5 it means successful pleurodesis. In our study, the first group where pleurodesis is done using tetracycline 1 patients showed a lung sliding score of less than 5 and seven patients had failed pleurodesis. In the second group, when using fluorouracil all patients had successful pleurodesis. In the third group, by using povidoneiodine six had successful pleurodesis and two patients had failed pleurodesis. In the fourth group, where pleurodesis is done spontaneously using IPC four patients showed a lung sliding score of less than 5 and one patient had failed pleurodesis.
Bakr et al. [8] , study was carried out on 40 patients with MPE (23 patients had right and 17 patients had left pleural effusions), consisted of four women and 36 men, with age ranging from 45 to 76 years, admitted in, and referred to, the Chest Department, Menoufiya University from July 2010 to July 2012.
The MPEs were either of primary pleural origins (malignant mesothelioma) in 14 patients or of metastatic etiology in 26 patients. Ten cases were due to metastatic adenocarcinoma of unknown origin and 16 cases were due to metastasis from different origins.
In the doxycycline group, complete response occur in 80% of the patients, whereas in 10% of the patients partial response occurred and failure in 10%. In povidone-iodine complete response occurred in 70% of the patients, partial response in 10%, and failure in 20%. In the fluorouracil group, complete response occurred in 40% of the patients, partial response in 10%, and failure in 50%.
The study of El-Kolaly et al. [7] included 45 patients with recurrent MPE who were enrolled into three groups; 15 patients in each one, and were subjected to pleurodesis using three chemical agent: vincristine (2 mg), viscum (100 mg), and povidone-iodine (20 ml). All patients were subjected to the thoracotomy tube for drainage of pleural fluid; then sclerosing agents were instilled intrapleurally through the tube. Vincristine, viscum, and povidone-iodine resulted in complete pleurodesis in 53.3, 73.3, and 73.3%, respectively. Failed pleurodesis was higher in the vincristine group (26.7%) but in viscum and iodine groups it was 13.3 and 20%, respectively. 
A retrospective study was carried out by Tettey et al. [5] to establish the effectiveness of tetracycline pleurodesis on 83 cases of MPE. Of these, 23 (61%) women showed complete response. In five (16%) women partial response was displayed, and in 10 (23%) no response was achieved.
In the study of Godazandeh et al. [2] , 36 patients who underwent pleurodesis by a thoracostomy tube and instilling povidone-iodine were enrolled. The response to this procedure was complete in 26 (72.2%) patients and partial in seven (19.4%) patients. Treatment failure was noticed in three (8.3%) patients. The overall rate of success was 91.6%.
Wong et al. [14] study was done between 2010 and 2014 and aimed to detect the safety of an IPC in the management of recurrent symptomatic MPE. A total of 23 IPCs were inserted in 22 patients with MPE, including 15 (65.2%) cases with metastatic lung cancer. Ten (43.5%) cases achieved minimal output, in patients the pleural catheter was removed without reaccumulation of effusion (i.e. spontaneous pleurodesis). Factors associated with minimal output were shorter time from first appearance of MPE to catheter insertion (P=0.017), the absence of trapped lung (P=0.036), and longer time from catheter insertion (P=0.007).
Conclusion
Thoracic US is an easy and accurate method for the detection of successful pleurodesis. Fluorouracil and povidone-iodine carry better prognosis than tetracycline and spontaneous pleurodesis.
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